A new collaborative platform, ADME-One, has been launched by Ginkgo Datapoints, Tangible Scientific, and Inductive Bio, signaling a significant shift…
Read More
Blazing new paths for biotech
For the past several years, success has grown increasingly elusive for American biotech firms, a stark contrast to the boom…
Read More
Boehringer Ingelheim eyes MASH as the next front for survodutide, a GLP-1/glucagon receptor dual agonist.
For decades, metabolic dysfunction-associated steatohepatitis (MASH), the more severe inflammatory form of fatty liver disease, was a silent epidemic, often…
Read More
ADA Conference Concludes with Groundbreaking GLP-1 Trial Results Amidst Unprecedented Protests Over Science Policy
The annual scientific sessions of the American Diabetes Association (ADA) this week served as a pivotal platform for unveiling cutting-edge…
Read More
J&J Poster Puts Spravato Remission Data at Center of Treatment-Resistant Depression Growth Push
More than six decades after Calvin Stevens first synthesized ketamine at Parke-Davis while searching for a safer anesthetic, the molecule…
Read MoreHow CTF is trying to rescue pharma’s shelved rare disease drugs
More than 5,000 potentially life-changing treatments for rare diseases are currently languishing on pharmaceutical company shelves, representing a vast reservoir…
Read More
CEPI Fast-Tracks Ebola Vaccine Candidates from IAVI, Moderna, and Oxford to Combat Bundibugyo Outbreak
The Coalition for Epidemic Preparedness Innovations (CEPI) has announced the urgent fast-tracking of three investigational vaccine candidates aimed at combating…
Read More
Pharmaceutical R&D Returns Soar to 7% Driven by GLP-1 Blockbusters, Raising Sustainability Questions for the Industry
After a period characterized by uneven growth and strategic recalibrations in the wake of global health challenges, a key metric…
Read More
Canada Makes History as First G7 Nation to Approve Generic Semaglutide, Sparking Global Debate on Patent Enforcement and Drug Access
In a landmark decision poised to reshape the landscape of diabetes and obesity management, Health Canada has granted authorization to…
Read More
Beyond PD-1: The drugs reshaping cancer treatment at ASCO 2026
The biotechnology sector, a critical engine of medical innovation, is experiencing a robust resurgence, marking a significant turnaround from recent…
Read MoreYOU MAY HAVE MISSED
